Journal of Natural Products · 2002 · 54 citations · 4 references
Life SciencesMicrobiologyPharmacologyMedical MicrobiologyMicrobial PathogenesisMycologyAntifungal AgentsAntifungal PharmacologyAntifungal TherapyFungal Cell BiologyFungal InfectionsFungal PathogenesisCandida Albicans InfectionCandida PharmacologyCandida TherapyFilamentous FormMorphological TransformationNovel Antifungal Drug Development
Carvone and perillaldehyde were shown to inhibit the transformation of Candida albicans to a filamentous form at concentrations far lower and more biologically relevant than the concentrations necessary to inhibit growth. This morphological transformation is associated with C. albicans pathogenicity; hence these naturally occurring monoterpenes are potential lead compounds in the development of therapeutic agents against C. albicans infection.
4
Mark L. Anderson, Frank C. Odds · Mycoses · 1985 · 36 citations
Life Sciences, Biology, Microbiology +13